CBS 2019
CBSMD教育中心
English

推荐文献

科研文章

荐读文献

2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions Association between urinary dickkopf-3, acute kidney injury, and subsequent loss of kidney function in patients undergoing cardiac surgery: an observational cohort study Management of two major complications in the cardiac catheterisation laboratory: the no-reflow phenomenon and coronary perforations A Randomized Trial Comparing the NeoVas Sirolimus-Eluting Bioresorbable Scaffold and Metallic Everolimus-Eluting Stents Better Prognosis After Complete Revascularization Using Contemporary Coronary Stents in Patients With Chronic Kidney Disease Advances in Coronary No-Reflow Phenomenon-a Contemporary Review Microthrombi As A Major Cause of Cardiac Injury in COVID-19: A Pathologic Study Qualitative Methodology in Cardiovascular Outcomes Research: A Contemporary Look Guidelines in review: Comparison of the 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes and the 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
|<<... 13 14 15 16 17 18 19 ...>>|

Review Article2003 Oct;60(2):194-201.

JOURNAL：Catheter Cardiovasc Interv. Article Link

Society of cardiac angiography and interventions: suggested management of the no-reflow phenomenon in the cardiac catheterization laboratory

Klein LW, Kern MJ, Interventional Cardiology Committee of the Society of Cardiac Angiography and Interventions. Keywords: no-reflow phenomenon; CathLab

LINK

Please click on "Article Link" on the right side to get further access.
>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top